Kasey Marie Murphy

Recommended Articles

• Diagnosis and Treatment of Leukemia

  Leukemia is defined as the cancer of blood or bone marrow which is responsible for the production of blood cells. A person who has leukemia generally suffers from an abnormal production of blood cells, especially leukocytes, also known as white blood cells, that are responsible for protecting the...

• Tonsil Research Shows Promising Results for Lymphomas and Autoimmune Diseases

  So, what does this mean exactly? Two scientists were studying at Australian National University (ANU) and discovered that particles once thought to only exist within the neurons of the brain also exist within the immune system. The immune system as a whole does an amazing job of targeting pathogens,...

• Recovering From Anal Fissure Surgery

  An anal fissure is normally the result of the overstretching of the anal mucosa or moist tissue. It can overstretch due to a number of reasons such as passing extra-large and/or hard stools, constipation, low blood flow to the area, excessive diarrhea, dietary choices, and childbirth among others....

• Can a Piercing Ease Fibromyalgia Pain?

  Fibromyalgia is a chronic pain syndrome that affects approximately 3 to 9 million American adults. The symptoms of fibro include painful, tender joints and awful body pain. These tender joints are sensitive to pressure in fibromyalgia patients. The healthcare community doesn't fully understand what...

• When Procedure Safety Concerns are Missed in Nursing

  The Universal Protocol is an integral part of practicing medicine, particularly in surgical and otherwise invasive procedures. The protocols were put in place to ensure that the right procedure is performed on the correct patient, so that not only are signs of adverse reactions to sedatives and...

• FDA Approves Orkambi to Treat Young Children with Cystic Fibrosis

  Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...